Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05033> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05033 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05033 label "INCB7839 [drugbank:DB05033]" assertion.
- drugbank:DB05033 seeAlso DB05033 assertion.
- drugbank:DB05033 description "INCB7839 is a novel, orally available ADAM metalloprotease inhibitor that is designed to block activation of the epidermal growth factor (EGFR) pathways. It represents a potentially important new class of targeted breast cancer therapy. It has shown promising clinical activity in heavily pretreated, refractory breast cancer patients." assertion.
- drugbank:DB05033 identifier "drugbank:DB05033" assertion.
- drugbank:DB05033 title "INCB7839" assertion.
- drugbank:DB05033 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05033 drugbank_vocabulary:drugbank-id "DB05033" assertion.
- drugbank:DB05033 bio2rdf_vocabulary:x-identifiers.org DB05033 assertion.
- drugbank:DB05033 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05033" assertion.
- drugbank:DB05033 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05033 bio2rdf_vocabulary:identifier "DB05033" assertion.